Who's joining — and leaving — Incyte Corporation.
Leadership hires, departures, and promotions from SEC 8-K filings — dated, named, and cited. The record shows the moves; a brief shows what they mean for your offer.
Where its leaders come from
Anthos Therapeutics, Inc. ×1
Recent leadership moves on the record
- Pablo J. Cagnoni— promotion: President, Incyte and Global Head of Research and Development2026-03-26filing
- Steven H. Stein— promotion: Executive Vice President, Chief Medical Officer and Head of Late-stage Development2026-03-26filing
- William J. Meury— departure: President, Incyte2026-03-26filing
- Mohamed Issa— promotion: Executive Vice President and Head of U.S. Commercial2026-03-26filing
- Hervé Hoppenot— retirement: Chairman and Chief Executive Officer2025-12-12filing
- Christiana Stamoulis— departure: Executive Vice President and Chief Financial Officer2025-09-16filing
- Thomas Tray— promotion: principal financial officer2025-09-16filing
- Hervé Hoppenot— retirement: special advisor to the Company’s Chief Executive Officer2025-06-26filing
- William J. Meury— hire: President and Chief Executive Officer (from Anthos Therapeutics, Inc.)2025-06-26filing
- Barry P. Flannelly— retirement: Executive Vice President, General Manager, North America2025-01-06filing
Have an offer from Incyte Corporation?
See exactly where your number sits in the certified band — free. Or get the full brief: company health, role risk, and the negotiation playbook, every claim cited. Ready in about ten minutes · seven-day refund.